ESC 365 - Doctor Leslie Cho

Speaker illustration

Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)

Member of:

Leslie Cho, MD, is Director of the Cleveland Clinic’s Women’s Cardiovascular Center. She is also Section Head, Preventive Cardiology and Rehabilitation and the Chief Quality Officer in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. She is a professor of Medicine at Cleveland Clinic Lerner School of Medicine Case Western Reserve Medical School. Dr. Cho is board-certified in interventional cardiology, cardiovascular medicine, and internal medicine. Dr. Cho’s clinical research interests are women and heart disease and the role of new treatments for hyperlipidemia and novel risk factor. She serves on multiple steering committees for international randomized controlled trials in cardiology. She is a special consultant to the FDA and is the chair elect for ACC CVD in Women group.

Sessions Presentations Articles

Meet the Trialist - ALL-HEART

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session type: Meet the Trialists

New insights into sex differences in acute coronary syndromes

Event: ESC Congress 2019

Topic: Treatment

Session type: Symposium

Diet and risk reduction of cardiovascular disease - Evidence, controversies, and consensus

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options

Event: ESC Congress 2018

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Women's vessels: another mystery

Event: ESC Congress 2017

Topic: Pathophysiology, epidemiology

Session type: Symposium

Cardiovascular risk reduction and dyslipidaemia management: current state and future therapies

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session type: Satellite Symposium

Lipid-lowering agents - New perspectives

Event: ESC Congress 2016

Topic: Drug therapy

Session type: Moderated Posters

Cardiovascular risk reduction and lipid management: state of the science

Event: ESC Congress 2016

Topic: Metabolism and metabolic syndromes

Session type: Satellite Symposium

Prevention 360: Strategies for Managing Cardiovascular Risk

Event: ESC Congress 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session type: Satellite Symposium

ESC 365 is supported by